Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-08-20 Greenstreet Yvonne Chief Executive Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −15,000 2,352
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Exercise or conversion 10b5-1 +6,667 $97.72 $651K 20,848
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Exercise or conversion 10b5-1 +14,058 $85.00 $1.2M 34,906
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −1,421 $268.66 $382K 33,485
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −9,662 $270.17 $2.6M 23,823
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −5,736 $271.32 $1.6M 18,087
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −3,913 $272.43 $1.1M 14,174
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −1,158 $273.73 $317K 13,016
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −135 $274.65 $37K 12,881
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Exercise or conversion · Stock Option (right to buy) 10b5-1 −14,058 2,192
2024-08-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Exercise or conversion · Stock Option (right to buy) 10b5-1 −6,667 0
2024-08-06 Ausiello Dennis A Director Exercise or conversion 10b5-1 +11,250 $131.21 $1.5M 11,386
2024-08-06 Ausiello Dennis A Director Exercise or conversion 10b5-1 +9,000 $105.26 $947K 20,386
2024-08-06 Ausiello Dennis A Director Sale 10b5-1 −1,627 $259.56 $422K 18,759
2024-08-06 Ausiello Dennis A Director Sale 10b5-1 −3,742 $260.40 $974K 15,017
2024-08-06 Ausiello Dennis A Director Sale 10b5-1 −6,212 $261.63 $1.6M 8,805
2024-08-06 Ausiello Dennis A Director Sale 10b5-1 −4,367 $262.79 $1.1M 4,438
2024-08-06 Ausiello Dennis A Director Sale 10b5-1 −3,408 $263.72 $899K 1,030
2024-08-06 Ausiello Dennis A Director Sale 10b5-1 −632 $264.95 $167K 398
2024-08-06 Ausiello Dennis A Director Sale 10b5-1 −262 $266.45 $70K 136

Page 42 of 80 · 1,590 trades